This paper reports the synthesis and characterization of ZnO nanoparticles prepared by soft chemical process. The nanoparticles of ZnO possess wurtzite hexagonal phase and were used for the induction of cell death in malignant human T98G gliomas, KB epithermoids and HEK normal non-malignant kidney cells. By applying ZnO nanoparticles, the cells exhibit that the nanoparticles are more efficacious on T98G cancer cells, moderately effective on KB cells and least toxic on normal human HEK cells. The results demonstrated that the treatment with ZnO nanoparticles sensitize T98G cells by increasing both the mitotic (linked to cytogenetic damage) and interphase (apoptosis) death. The ZnO nanoparticles behave as genotoxic drugs, since they induce a micronucleus formation in cells. The present study could be helpful in designing more potent anticancer agents for the therapeutic uses.
INTRODUCTION
Cancer is a complex disease which caused due to the cellular malfunction. The cellular malfunction occurred because of two reasons; the first is due to a carcinogeninduced or natural mutation, gene amplification or chromosomal translocation while the second is apoptosis complex caused due to genetic mutations. 1a The cancer cells will be developing only when these two reasons will occur in the same cell at the same time. Therefore, the transformation of normal to cancerous cell involves three distinct phases i.e., initiation, promotion and progression.
2 Cancer is a serious disease and according to a recent report of National Institutes of Health, USA, published in 2010 that more than 1.5 million new cases have been diagnosed in USA with overall cost of US$263. 8 billion. 1b Due to these facts, this serious, complex and complicated diseases, i.e., cancer, is one of the most widely researched disease for medical practitioners and scientists. With the fast growth of nanotechnology in multidisciplinary fields, scientists are working extensively to apply this extremely wide and versatile field of science for the cancer treatment and it is expected that nanotechnology will bring a new methods and approaches for cancer diagnosis, treatment, and prevention. [1] [2] [3] [4] [5] [6] [7] [8] Working in this direction, scientists revealed that the nanoscale materials which exhibit unique physicochemical characteristic due to their size, surface area and enhanced reactivity can easily enter in cells, protein, etc. and hence can effectively participate in various biological systems.
1-9 Among various nanomaterials, ZnO nanostructures possess excellent properties and wide applications. Due to excellent properties of ZnO, such as wide band gap, high-exciton energy, lowcost synthesis, high-specific surface area, high conductivity, biocompatibility nature and so on, it is widely used for variety of applications, to name a few, photocatalysis, [10] [11] [12] [13] [14] [15] [16] Over other applications, it is also used as photosensitizer (PS) in photodynamic therapy (PDT) as their light energy usually matches with the maximum absorption of wave length to the targeting drugs. The molecules absorb this energy and transform to an excited singlet state and again return to their native or original state. This is followed by the transfer of energy to the oxygen molecule or to other substrate molecule in the surroundings which then react with the oxygen. 17 Recently, few reports have appeared in the literature related with the utilization of ZnO nanomaterials for cancer detection and therapy. Recently, Wahab et al. have studied the ZnO nanoparticles induction of oxidative stress in Cloudman S91 melanoma cancer cells and reported in the literature. 18 Park et al. presented the comparison of the toxic mechanism of ZnO nanomaterials by physicochemical characterization and reactive oxygen species (ROS) properties. 19 Ostrovsky et al. have demonstrated the cytotoxic effects of 60 nm sized ZnO nanoparticles, prepared by ultrasonic process, towards human glioma cell lines U 87, A 172, U 251, LNZ 308, LN 18, LN 229, and on human normal astrocytes as well as on breast and prostate cancer cells. 20 After the in-vitro studies on various animal and human cells, the effect of various ZnO nanoparticles on genetic material or chromosome damage remained only a question. Therefore, in this study we have focused on clonogenicity and genotoxicity analyses of ZnO nanoparticles in cancer cells.
The present work represents the cytotoxicity/ genotoxicity studies against Human T98G Gliomas (Brain cancer), KB epidermoid (Skin Cancer) and HEK normal kidney cells using ZnO nanoparticles. These nanoparticles were used as a target material for inducing cell death (apoptosis) in malignant cells. The % viability, morphologies, clonogenicity and micronucleus formation in malignant cells at different incubation time were also studied. Moreover, the comparison studies were also performed between micronucleus and apoptosis frequencies in human T98G gliomas with ZnO nanoparticles.
EXPERIMENTAL DETAILS Synthesis and Characterization of ZnO Nanoparticles
The entire chemicals for the synthesis of ZnO nanoparticles were purchased for Sigma-Aldrich and used without further purification. The nanoparticles were synthesized by simple and facile solution process by using zinc acetate dihydrate (Zn(CH 3 COO) 2 · 2H 2 O; Zn(OAc) 2 ) and sodium hydroxide (NaOH). In a typical reaction process, 1 M Zn (OAc) 2 was dissolved in 100 mL of distilled water (DW) in a round bottom flask. Consequently, appropriate amount of NaOH dissolved in 50 mL DW, was added drop-wise to the Zn(OAc) 2 solution under continuous stirring for 10 min. After stirring, the resultant solution was refluxed at 90 C for desired time. White colored precipitate was obtained which was washed several times with water, ethyl alcohol and acetone, sequentially and dried for few hours at 50 C. The synthesized powder was characterized in terms of their morphological structural and compositional properties.
The morphology of the prepared powder was examined by field emission scanning electron microscopy (FESEM) while the structural properties was characterized by X-ray diffraction ((XRD) with Cu-K radiation ( = 1 54178 Å) in the range of 20 to 65 at the scan speed of 8 /min. The chemical composition of as-synthesized material was checked by Fourier transforms infrared (FTIR) spectroscopy in the range of 4000-400 cm −1 .
DNA Binding
The fluorescence quenching titration at increasing ZnONPs to ctDNA molar ratios has been performed. Human Cell Culture T98G, KB and HEK cells used in the present studies were purchased from Korean cell line bank (SNU, Seoul). These cell lines were cultured in 75 cm 2 culture flasks (Corning, USA) using Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1% nonessential amino acids, 1% glutamine, penicillin (100 IU/ml) and streptomycin (100 mg/ml) (all from Euroclone, UK). All cultures were maintained at 37 C, 95% relative humidity and 5% CO 2 . The growth medium was changed every other day until the time of use. T98G, KB and HEK cells passage number 25, 12, and 19, respectively were used in the cytotoxicity tests. Prior to each cytotoxicity test, the cells were harvested using trypsin-ethylene diamine tetraacetic acid (EDTA)-PBS solution (with 0.25% trypsin-0.05 mM according to the distributor's instructions) and diluted at a density of 5 × 10 5 cells/ml in MTT assays. Stock cultures were passaged every third day after harvesting the cells with 0.05% trypsin and seeding 8 × 10 3 cells/cm 2 in tissue culture flasks to maintain the cells in the exponential phase. All experiments were carried out in exponentially growing cells. The cell suspension was seeded into 96-well plates (Corning, USA) at 100 l/well, and incubated for approximately 20-24 h before tests in order to reach confluency. Before the cells were seeded into 96-well plates, the plates were treated with 0.01% poly-D-lysine solution (SigmaAldrich, Germany).
In Vitro Cell Viability Assay Cells were seeded in 96-well plates at a concentration of 2-4 × 10 3 cells/well in 200 L of complete media and incubated for 24 h at 37 C in 5% CO 2 atmosphere to allow for cell adhesion. Stock solutions (4 mg/ml) of the nanoparticles made in PBS, and then diluted upto 2 mg/ml in incomplete media. The 2 mg/ml solutions were further diluted up to 0.45 g/ml in incomplete media for treatment against cell lines, where 100 L of nanoparticle solutions added to 100 L, respectively, of fresh medium in wells to give final concentrations of 2000-0.45 g/ml. All assays were performed in two independent sets of quadruplicate tests. Control group containing no structures was run in each assay. Following 48 h of exposure of cells to NPs, each well was carefully rinsed with 200 L PBS buffer. Cytotoxicity was assessed using MTT (3-[4,5-dimethyl thiazol-2yl]-2,5-diphenyltetrazolium bromide). MTT solutions 20 L (5 mg mL −1 dd H 2 O) along with 200 L of fresh complete media were added to each well and plates were incubated for 4 h. Following incubation, the medium was removed and the purple formazan precipitate in each well was sterilized in 200 L DMSO. [23] [24] [25] Absorbance was measured using Techano microplate reader (molecular device) at 570 nm and results are expressed as IC 50 evaluated form % viability which is directly proportional to metabolic active cell number. Percentage (%) viability was calculated from the equation mentioned below: % Viability = OD in sample well/OD in control well × 100
Growth Kinetics Assay T98G, KB and HEK cells were seeded at 7000-8000 cells/cm 2 and their proliferation kinetics was studied at 24, 48 and 72 h intervals following trypsinization and counting total cells per plate using a Hemocytometer. 25 
Clonogenic Assay
Clonogenic assay or colony formation assay is an in vitro cell survival assay based on the ability of a single cell to grow into a colony. The colony is defined to consist of at least 50 cells. The assay essentially tests every cell in the population for its ability to undergo "unlimited" division. Clonogenic assay is the method of choice to determine cell reproductive death after treatment with ionizing radiation, but can also be used to determine the effectiveness of other cytotoxic agents. 25 Only a fraction of seeded cells retains the capacity to produce colonies. Before or after treatment, cells are seeded out in appropriate dilutions to form colonies in 1-3 weeks. After harvesting with 0.05% trypsin, 150-400 (depending on the treatment) cells were plated 10-14 h before treating with varying concentrations of NPs in DMEM at 37 C. Cultured cells were treated with doses (7.8 to 125 g/ml) of nanoparticles. After the treatment, cells were incubated in dark under humidified, 5% CO 2 atmosphere at 37 C for 8-10 days to allow colony formation. Colonies were fixed with methanol and stained with 1% crystal violet. Colonies of more than 50 cells were counted and the surviving fraction (SF) was calculated. Clonogenic survival curves were constructed from three independent experiments by leastsquares regression fitting averaged survival levels.
Micronuclei Formation (MNi)
Air-dried slides containing acetic acid-methanol (1:3 V/V) fixed cells were stained with Hoechst-33342 (10 g/ml in PBS (0.1 M), disodium phosphate (0.45 M) buffer containing 0.05% Tween-20 detergent). Slides were examined under the fluorescence microscope using an UV excitation filter. Fluorescent nuclei were visualized using a blue emission filter. Cells containing micronuclei were counted from > 1000 cells by employing the criteria of Countrymen and Heddle.
The formation is linked to cell proliferation, the micronuclei frequencies were normalized with respect to the cell numbers.
Detection of Apoptotic Cells
The percentage of cells undergoing apoptosis was determined microscopically using Hoescht 333242 labeled cells. At least 1000 cells were counted and the percentage of apoptotic cells determined from slides prepared for micronuclei formation.
RESULTS AND DISCUSSION

Properties of ZnO Nanoparticles
The general morphology of as-prepared ZnO product was examined by FESEM. Figures 1(a) and (b) exhibits the typical low and high-magnification images which confirmed that the synthesized ZnO products are nanoparticles. From the low-resolution FESEM image, it is clear that the nanoparticles are grown in high density. Moreover, due to high density growth aggregation in the nanoparticles can also be seen. Most of the nanoparticles exhibit spherical shapes with the average diameters in the range of 20 ± 5 nm. In addition to spherical shape, some elongated nanoparticles were also seen in the observed FESEM micrograph ( Fig. 1(b) ). To examine the crystallinity and crystal phases, the synthesized nanoparticles were examined by X-ray diffraction. shows the typical XRD pattern of as-synthesized ZnO nanoparticles. All the observed diffraction reflection in the pattern is well-matched with the wurtzite hexagonal phase, pure ZnO with the lattice constants of a = 3 249 Å and c = 5 206 Å. Moreover, the observed diffraction reflections are well matched with the reported literature and Joint Committee on Powder Diffraction Standards (JCPDS 36-1451). 12 b No other reflection except reflections for pure wurtzite hexagonal phase ZnO was detected in the observed pattern which further confirms the purity of the synthesized nanoparticles. The appearance of sharp and strong intensity diffraction reflections further confirms the well-crystallinity of the prepared nanoparticles.
The chemical composition of as-synthesized ZnO nanoparticles was examined by FTIR spectroscopy. is corresponding to metal-oxygen (Zn O) bonds and hence confirms the formation of ZnO.
12 26 The peak centred at 1430 cm −1 can be attributed to C-O vibration of acetate group while the peak originated at ∼ 1579 cm −1 could be assigned as C O.
27-28 A very small peak at 2364 cm −1 was also observed which was related with CO 2 . 26 Appearance of a broad peak at 3300 cm −1 is belongs to the adsorbed water molecule. In case of nanoparticles, the red shift in the emission spectra indicates that on binding to the DNA, the ring substituent on the fluorophore could slide into the base pairs, illustrating that they were in an environment in which it was unable to hydrogen bond with the solvent water molecules. The red shift observed at lower concentration of DNA, also indicated the higher affinity between DNAZnO nano particles. The fluorescence quenching constant (K sv ) was evaluated using the Stern-Volmer equation
where F 0 and F are the fluorescence intensities in the absence and presence of DNA, respectively, K SV is the Stern-Volmer quenching constant, which is a measure of the efficiency of quenching by DNA. The titration data were used to construct a plot of F 0 /F versus [DNA] and shown in Figure 2(b) . The K SV obtained from the slope of the linear line was 4 5 × 10 4 Lmol −1 . The Stern-Volmer plot is linear, indicating that only one type of quenching process occurs, i.e., either static or dynamic quenching. 22 Moreover, when the molecules bind independently to a set of equivalent sites on a macromolecule, the equilibrium between free and bound molecules is given by the equation mentioned below:
where K is the binding constant. Thus, a plot of log F 0 − F /F versus log [DNA] (Fig. 2(b) ) can be used to determine K.
Inhibitory Effect of Nanoparticles on the Proliferation of T98G Gliomas, KB Epidermoid cancer and Normal HEK Cells
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assay has been widely accepted as a reliable way to measure the cell proliferation rate, and conversely when metabolic events lead to apoptosis or necrosis. 23 25 The data obtained by MTT assay showed that nanoparticles had inhibitory effects on the growth of T98G gliomas, KB epidermoid cancer and HEK normal cells in dose and time dependent manners. The ZnO nanoparticles are effectively inhibited the T98G cells growth after 24 h of treatment with the IC 50 value of 16.8 (± 2.2) g/ml.
The NPs were also moderately inhibited the KB cells growth when compared with IC 50 obtained on T98G cells. The nanoparticles shows moderate toxicity against KB cells and their IC 50 values was 38.4 g/ml. The data obtained from MTT assay on HEK cells suggest that the nanostructures are less cytotoxic on HEK (normal) cells when compared with result obtained on T98G and KB cells at all effective concentration and time intervals. IC 50 values of the nanostructures on HEK cells were found for the nanoparticles are 52.9 g/ml. We also found inhibitory effect of structures on HEK cells is dose dependent, at higher concentration (250-1000 g/ml) the inhibitory effect is almost same as shown on T98G and KB cells. However the structures are safe against normal HEK cells at less concentration. This is worth to mention that the colchicine and other antibiotics available in market were found to be more toxic on HEK cells than these nanoparticles and their IC 50 range from 19-64.1 g/ml (data not shown here). The nanoparticles are most potent structure against T98G and less toxic to normal HEK cells at effective concentrations (Fig. 3) . We have used the nanoparticles for our further study on growth kinetics, clono genic inhibition and micronucleus formation of T98G brain cancer cells.
Effect of ZnO Nanoparticles on the Growth Kinetics of T98G Cells
The effects of zinc oxide nanoparticles on the growth kinetics of T98G cells were also studied and presented in this paper. In these experiments, cells were incubated with nanoparticles for 24, 48 and 72 h and counted by hemocytometer. It was found that at 7.8, 15.6, 31.2, 62.5 g/ml concentrations of ZnO-NPs inhibited the growth of T98G cells upto 29%, 58%, 60% and 86% respectively at 24 h, 38%, 58%, 65% and 85% respectively at 48 h and 40%, 59%, 67% and 88% respectively at 72 hour after treatment ( Fig. 4(a) ). data shows that the growth of T98G cells is much depends on doses of ZnO-NPs, whereas time dependent changes are not much significant (Fig. 4) .
Inhibitory Effects of ZnO Nanoparticles on the Colony Forming Capacity of T98G Cells Figure 5 exhibits the graph for the effect of ZnO nanoparticles on colony forming capacity and survival of exponentially growing human gliomas cell lines T98G studied by macro colony assay (clonogenecity). Data presented in the graph were mean values from at least three independent observations. It was observed from the obtained results that the extent of cell death was marginally higher at higher concentrations (Fig. 5) . It is also seen that the T98G cells treated with different concentrations of ZnO nanoparticles (7.8-62.5 g/ml) resulted in a dose dependent decline in the cell survival as evidenced by the reduction in the number of colonies formed. Interestingly, it was observed that even at lower ZnO nanoparticles concentration (7.8 g/ml) showed a reduced cell survival by 65%. However, a drastic decline in the cell survival was observed after exposure to 31.2 and 62. ZnO nanoparticles are significantly inhibiting the colony forming capacity of single cell in the T98G cancer cells at concentration ranges of 7.8-62.5 g/ml.
Cytogenetic Damage Studies by ZnO Nanoparticles of T98G Cells Mitotic death (linked to cytogenetic damage) and inter-phase death (apoptosis) together account for the cytotoxicity of many chemical agents, although the relative contributions of the two death processes vary among the type of damaging agent. 25 To investigate the modifications Figure 5 . Effect of nanoparticles on colony forming capacity and survival of exponentially growing human glioma cell lines T98G studied by macro colony assay. Data presented are mean values from at least three independent observations. of cytogenetic damage by the as-synthesized ZnO nanoparticles, we studied the treatment-induced micronuclei formation in gliomas (T98G cells). Since cell proliferation influences treatment induced micronuclei expression, the data from kinetic studies up to 24 h post treatment were analyzed. Untreated T98G cells exposed to vehicle (PBS) had normal micronuclei frequency which is 4.6% and apoptotic frequency 2.3% cells. At various concentrations of ZnO nanoparticles (7.8, 15.6, 31.2 and 62.5 g/ml), it was found that the frequency of cells with micronuclei is 8.4%, 16.12%, 19.11% and 21.64%, respectively (Fig. 6 ). Interestingly, it was observed that the micronuclei formation in the cell population was enhanced in a dose dependent manner, i.e., it increases with increasing the concentration of the ZnO nanoparticles. The nanoparticles exhibit significant micronuclei frequency with apoptotic bodies, i.e., in the range of 8.4-21.64% at all effective concentrations which is 2-4 folds greater compared with untreated control group. 
Microscopic Apoptosis Studies of T98G Cells Using ZnO Nanoparticles
The apoptotic mode of the cell death in the cell line was confirmed by microscopy and flow cytometry and shown in Figure 7 . The changes in the cell morphology were characterized by typical chromatin condensation and nuclear fragmentation with disruption of plasma membrane integrity. Untreated T98G cells (negative control) exposed by vehicle (PBS) have 2.3% apoptotic frequency. T98G cells treated with 7.8, 15.6, 31.2 and 62.5 g/ml concentration of nanoparticles, the frequency of apoptotic is observed 5.4%, 9.1%, 11.2% and 15.6%, respectively (Fig. 7) . The data shows that the apoptotic cells frequency is increases 1-2 fold with the treatment of nanoparticles at 24 h.
CONCLUSIONS
In summary, ZnO nanoparticles were synthesized by simple and facile low-temperature soft chemical process. The prepared nanoparticles were characterized in terms of their morphological, structural and compositional properties which revealed that the synthesized products are nanoparticles, grown in high density, possessing wurtzite hexagonal phase pure ZnO. The synthesized nanoparticles were used for the induction of cell death and it was found that the prepared nanoparticles showed an unusually broad dosage range of activity against the malignant human T98G gliomas, KB epithermoids and HEK normal nonmalignant kidney cells. 
